Hester Biosciences Share Price Target For Tomorrow, Next Week & Next Month
Hester Biosciences Limited | |||
 | Price: ₹1,881.40 (+1.66%) | ||
| 52 Week Low: ₹1,242.95 52 Week High: ₹3,379.00 | |||
| Market Capital: 2,026.24 Crore (Smallcap) | |||
| Healthcare -> Drug Manufacturers—Specialty & Generic | |||
Hester Biosciences Stock Comparison: Hester Biosciences vs IOL Chemicals and Pharmaceuticals Limited | Hester Biosciences vs Themis Medicare | Hester Biosciences vs Suven Life Sciences | Hester Biosciences vs TTK Healthcare | Hester Biosciences vs Amrutanjan Health Care | Hester Biosciences vs Solara Active Pharma Sciences Limited | |||
Share Price HistoryHESTERBIO FinancialsTomorrow TargetYearly TargetsDividend HistoryNo BonusNo Split
Show Table of Contents
Hester Biosciences Recent Performance
Over the past 498 trading days, the value of Hester Biosciences's stock has gained ₹175.70 (+10.30%). On 17 Jul 2023, one share was worth ₹1705.70 and by 24 Jul 2025, the value jumped to ₹1881.40. During this period it created a highest high of ₹3370.86 and lowest low of ₹1242.95.
Hester Biosciences Share Price Target - Tomorrow
| Level | Value | Analysis |
|---|---|---|
| Tomorrow Target 3 | 2118.12 (+12.58%) | Technical Indicator: MA250 |
| Tomorrow Target 2 | 2070 (+10.02%) | Price Action: Jul 2025 High |
| Tomorrow Target 1 | 2027 (+7.73%) | Price Action: Feb 2025 High |
| Current Price | 1881.40 | Hester Biosciences's share price as of 24 Jul 2025 |
| Stop Loss 1 | 1767.7 (-6.05%) | Price Action: 02 Jun 2025 Low |
| Stop Loss 2 | 1746.24 (-7.19%) | Price Action: Oct 2023 High |
| Stop Loss 3 | 1720 (-8.58%) | Price Action: 06 May 2025 Low |
Summary
24 Jul 2025: Hester Biosciences finished the day at ₹1881.40, gaining ₹30.80 (+1.66%) in 1 day.
Our analysis for tomorrow predicts a potential movement of -8.58% to 12.58% with:
- Target prices: ₹2027 to ₹2118.12
- Support levels: ₹1767.7 to ₹1720
- Recent high: ₹1899.00
- Recent low: ₹1846.70
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Hester Biosciences Share Price Target - Next Week
| Level | Value | Analysis |
|---|---|---|
| Next Week Target 3 | 1994.4 (+6%) | Fibonacci Extension Level 50.00% |
| Next Week Target 2 | 1963.9 (+4.38%) | Price Action: 18 Jul 2025 High |
| Next Week Target 1 | 1934.74 (+2.83%) | Fibonacci Extension Level 23.60% |
| Current Price | 1881.40 | Hester Biosciences's share price as of 24 Jul 2025 |
| Stop Loss 1 | 1862.3 (-1.02%) | Price Action: 15 Jul 2025 Low |
| Stop Loss 2 | 1842 (-2.1%) | Price Action: 09 Jun 2025 Low |
| Stop Loss 3 | 1822 (-3.16%) | Price Action: 19 Jun 2025 High |
Weekly Target Summary
For next week, our analysis suggests a potential movement range of -3.16% to 6.01% with:
- Upper targets: ₹1934.74 to ₹1994.4
- Support levels: ₹1862.3 to ₹1822
Hester Biosciences Share Price Target - Next Month
| Level | Value | Analysis |
|---|---|---|
| Next Month Target 3 | 2118.12 (+12.58%) | Technical Indicator: MA250 |
| Next Month Target 2 | 2070 (+10.02%) | Fibonacci Extension Level 100.00% |
| Next Month Target 1 | 2042.3 (+8.55%) | Price Action: Apr 2025 High |
| Current Price | 1881.40 | Hester Biosciences's share price as of 24 Jul 2025 |
| Stop Loss 1 | 1838.9 (-2.25%) | Price Action: 28 May 2025 High |
| Stop Loss 2 | 1820.1 (-3.26%) | Price Action: 17 Jun 2025 Low |
| Stop Loss 3 | 1800.6 (-4.3%) | Price Action: 29 May 2025 Low |
Monthly Target Summary
Looking ahead to next month, technical analysis indicates:
- Potential price movement: -4.29% to 12.58% with:
- Target range: ₹2042.3 to ₹2118.12
- Support levels: ₹1838.9 to ₹1800.6
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
